But these changes may bring about the need for increasing your electrolyte intake, to avoid fatigue, reduced exercise performanceOpens in a new tab, brain fog, or other symptoms
& Neggers, S
The following table describes GLP-1 receptor agonists, their dosing frequency and key pharmacokinetic parameters: Cautions and Contraindications Adverse Effects Acute pancreatitis (rare) Injection site reactions Gastrointestinal disturbances (nausea, vomiting, diarrhoea dehydration and possible renal impairment) Increase in pancreatic enzymes: lipase and amylase (dulaglutide, tirzepatide and semaglutide) Cholecystitis and cholelithiasis Delayed gastric emptying (semaglutide, exenatide, dulaglutide, tirzepatide (diminishes over time)) Increased heart rate Diabetic retinopathy complications (semaglutide, particularly in insulin-treated patients with known diabetic retinopathy) Interactions GLP-1 receptor agonists do not interact via cytochrome P450 , but delayed gastric emptying may alter drug absorption
developed self-assembled DNA capsules that shield probiotics from gastric acidity while enabling inflammation-triggered release, thereby enhancing localized therapeutic gains 224
You can also contact your primary care provider or go to one of our Express Cares or Urgent Cares